title: When should a time at risk start in efficacy malaria vaccine trials?
authors.affiliation: Assistant Professor of Pharmacology, St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia. Electronic address: daejigu@gmail.com.
authors.forename: Dawit Asmamaw
authors.initials: DA
authors.lastname: Ejigu
mesh_terms: D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D017780:Malaria Vaccines / Q000276:immunology*; D016778:Malaria, Falciparum / Q000276:immunology
chemical_list: D017780:Malaria Vaccines